Works cited by this work

154 works

Work: A perspective on emerging therapies in metastatic colorectal cancer: Focusing on molecular medicine and drug resistance

Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications
Nida Iqbal, Nida Iqbal, Naveed Iqbal +1
Review article20146 citations
ABI
Comprehensive review of targeted therapy for colorectal cancer
Yuanhong Xie, Yingxuan Chen, Jing‐Yuan Fang
Review article20205 citations
ABI
Diagnosis and Treatment of Metastatic Colorectal Cancer
Leah H. Biller, Deborah Schrag
Review article20214 citations
ABI
The Role of mTOR Signaling as a Therapeutic Target in Cancer
N. V. Popova, Manfred Jücker
Review article20213 citations
ABI
AKT/PKB Signaling: Navigating the Network
Brendan D. Manning, Alex Toker
Review article20173 citations
ABI
Emerging Role of ERBB2 in Targeted Therapy for Metastatic Colorectal Cancer: Signaling Pathways to Therapeutic Strategies
Nannan Wang, Yuepeng Cao, Chengshuai Si +5
Review article20223 citations
ABI
Immune Checkpoint Inhibitors in Cancer Therapy
Yavar Shiravand, Faezeh Khodadadi, Seyyed Mohammad Amin Kashani +6
Review article20223 citations
ABI
Characteristics of the cancer stem cell niche and therapeutic strategies
Feng Ju, Manar Atyah, Nellie Horstmann +6
Review article20223 citations
ABI
Small Molecule EGFR Inhibitors as Anti-Cancer Agents: Discovery, Mechanisms of Action, and Opportunities
Tanzida Zubair, Debasish Bandyopadhyay
Review article20233 citations
ABI
Autophagy, cancer stem cells and drug resistance
Alexandra G. Smith, Kay F. Macleod
Review article20182 citations
ABI
VEGF/VEGFR-Targeted Therapy and Immunotherapy in Non-small Cell Lung Cancer: Targeting the Tumor Microenvironment
Yueshui Zhao, Sipeng Guo, Jian Min Deng +13
Review article20222 citations
ABI
The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer
Jennifer L. Hsu, Mien‐Chie Hung
Review article20162 citations
ABI
The ErbB/HER family of protein-tyrosine kinases and cancer
Robert Roskoski
Review article20132 citations
ABI
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?
Giuseppe Bronte, Nicola Silvestris, Marta Castiglia +10
Review article20152 citations
ABI
Vascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy
Gang Niu, Xiaoyuan Chen
Review article20102 citations
ABI
Microsatellite Instability in Colorectal Cancer
C. Richard Boland, Ajay Goel
Review article20102 citations
ABI
Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years
Mariusz Pańczyk
Review article20142 citations
ABI
The emerging clinical relevance of genomics in cancer medicine
Michael F. Berger, Elaine R. Mardis
Review article20182 citations
ABI
NTRK fusion-positive cancers and TRK inhibitor therapy
Emiliano Cocco, Maurizio Scaltriti, Alexander Drilon
Review article20182 citations
ABI
Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years?
Olivier Gires, Min Pan, Henrik Schinke +2
Review article20202 citations
ABI
Growth Factors, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now?
Constantin Ștefani, Daniela Miricescu, Iulia-Ioana Stănescu-Spînu +4
Review article20212 citations
ABI
Impact of<scp>DNA</scp>damage response defects in cancer cells on response to immunotherapy and radiotherapy
Daniel Czajkowski, Radosław Szmyd, Harriet E. Gee
Review article20222 citations
ABI
HER2 in Colorectal Cancer: The Long and Winding Road From Negative Predictive Factor to Positive Actionable Target
Selma Ahcene Djaballah, Francesca Daniel, A. Milani +2
Article20222 citations
ABI
DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities
Dana Jurkovičová, Christiana M. Neophytou, Ana Čipak Gašparović +1
Review article20222 citations
ABI
Resistance to targeted therapy in metastatic colorectal cancer: Current status and new developments
Yuanling Tang, Dandan Li, Jiayu Duan +2
Review article20232 citations
ABI